| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H38FN3O2 |
| Molecular Weight | 491.64 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=C(N3)C=CC=C4)OC(=O)C5CC5)C=C(F)C=C2
InChI
InChIKey=VHHVPDKNKPNKHY-JDXGNMNLSA-N
InChI=1S/C30H38FN3O2/c1-20(2)28-24-13-12-23(31)19-22(24)14-15-30(28,36-29(35)21-10-11-21)16-18-34(3)17-6-9-27-32-25-7-4-5-8-26(25)33-27/h4-5,7-8,12-13,19-21,28H,6,9-11,14-18H2,1-3H3,(H,32,33)/t28-,30-/m0/s1
| Molecular Formula | C30H38FN3O2 |
| Molecular Weight | 491.64 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 6.8 µM [IC50] | |||
| 6.8 µM [IC50] | |||
| 5.7 null [pIC50] | |||
| 5.7 null [pIC50] |
